Skip to main content

22 March 2023

Last updated: Wednesday 22 March 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

McKenna, Long & Aldridge
NDA Regulatory Science Ltd
MedNous
Transgene SA
Intercell AG
Genenta Science SpA
European Bioinformatics Institute
Consultant and MedNous Editorial Board Member
Amyl Therapeutics BV
MorphoSys AG

Interviewees and Contributers

Rosie Bannister
Mick Cooper
Pierre Meulien
Jytte Lyngvig
Alastair Smith
Jane Morrison
Shaun Grady
Frederic Triebel
Rob Brainin
Rudy Dekeyser

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Medivir has new CMO

Sunday 19 March 2023

New advisory board member at Pan Cancer T

Sunday 19 March 2023

Osivax appoints Chris Martin to board

Sunday 19 March 2023

Two changes to Novo Nordisk executive team

Sunday 19 March 2023

New deputy director at the FDA

Sunday 19 March 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form